Prostate Cancer - Results from #28500

Obese frailty, physical performance deficits, and falls in older men with biochemical recurrence of prostate cancer on androgen deprivation therapy: A case-control study - Abstract March 1, 2011

ACR appropriateness criteria postradical prostatectomy irradiation in prostate cancer - Abstract March 1, 2011

Prostate cancer outcome and tissue levels of metal ions - Abstract March 1, 2011

Preliminary study of the specific endothelin a receptor antagonist zibotentan in combination with docetaxel in patients with metastatic castration-resistant prostate cancer - Abstract March 1, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - Overview of management of radiation failures in prostate cancer - Session Highlights March 1, 2011

Experience with sunitinib in hormone-resistant metastatic prostate cancer that is unresponsive to docetaxel - Abstract February 28, 2011

What do prostate cancer patients die of? - Abstract February 28, 2011

Assessment of aggressiveness of prostate cancer: Correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy - Abstract February 28, 2011

Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy - Abstract February 28, 2011

Disease-specific mortality may underestimate the total effect of prostate cancer screening - Abstract February 28, 2011

Using large institutional or national databases to evaluate prostate cancer outcomes and patterns of care: Possibilities and limitations - Abstract February 28, 2011

Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4) - Abstract February 28, 2011

High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy - Abstract February 28, 2011

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection - Abstract February 28, 2011

Change in PSA level does not predict prostate cancer February 28, 2011

MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer - Abstract February 25, 2011

Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancer - Abstract February 25, 2011

Acceptance and durability of surveillance as a management choice in men with screen-detected, low-risk prostate cancer: Improved outcomes with stringent enrollment criteria - Abstract February 25, 2011

Depression related to (neo)adjuvant hormonal therapy for prostate cancer - Abstract February 25, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - Management of castration-resistant prostate cancer after initial chemotherapy - Session Highlights February 25, 2011

Page 1426 of 1434